Global Piracetam Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Piracetam Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
It is suitable for memory loss and mild to moderate brain dysfunction caused by various reasons such as acute and chronic cerebrovascular diseases, brain trauma, and various toxic encephalopathy. It is also used for children with mental retardation.
Piracetam Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2024. Global Piracetam Injection market is projected to reach US$ 24110 million in 2034, increasing from US$ 2608 million in 2024, with the CAGR of 37.3% during the period of 2023 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
Brain diseases have always been one of the most difficult areas for human beings to conquer. There are constant disputes over whether neuroprotective agents are life-saving drugs or panacea. The neuroprotective drug market is greatly influenced by evidence-based drug use and related policies. New drugs such as butylphthalide and edaravone dexaborneol are developing rapidly, and after the decline of many old drugs such as edaravone, oxiracetam, and gangliosides, they have taken over and become Dinghaishenzhen among neuroprotective drugs. In addition, piracetam, which is a gamma-aminobutyric acid analogue like oxiracetam, has also been recommended by multiple guidelines, bucking the trend and achieving market growth.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Piracetam Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Tianjin Jinyao Group Hubei Tianyao Pharmaceutical Co., Ltd.
Shandong Weigao Pharmaceutical
Chongqing Yaoyou Pharmaceutical
Harbin Pharmaceutical Group Sanjing Pharmaceutical
Yangzhou Pharmaceutical
Rapid Life Drugs & Healthcare
Mits Healthcare Private Limited
Psychocare
Shinepro Lifesciences Pvt. Ltd.
REPLEK FARM DOOEL
Dr Reddy's Laboratories Ltd
Heilongjiang Fuhe Pharmaceutical
Segment by Type
15ml
60mL
Other
Hospital
Clinic
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Piracetam Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Piracetam Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Piracetam Injection industry.
Chapter 3Historical (2018-2024) and forecast (2024-2034) volume and revenue analysis of Piracetam Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Piracetam Injection introduction, etc. Piracetam Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Piracetam Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Piracetam Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2024. Global Piracetam Injection market is projected to reach US$ 24110 million in 2034, increasing from US$ 2608 million in 2024, with the CAGR of 37.3% during the period of 2023 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
Brain diseases have always been one of the most difficult areas for human beings to conquer. There are constant disputes over whether neuroprotective agents are life-saving drugs or panacea. The neuroprotective drug market is greatly influenced by evidence-based drug use and related policies. New drugs such as butylphthalide and edaravone dexaborneol are developing rapidly, and after the decline of many old drugs such as edaravone, oxiracetam, and gangliosides, they have taken over and become Dinghaishenzhen among neuroprotective drugs. In addition, piracetam, which is a gamma-aminobutyric acid analogue like oxiracetam, has also been recommended by multiple guidelines, bucking the trend and achieving market growth.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Piracetam Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Tianjin Jinyao Group Hubei Tianyao Pharmaceutical Co., Ltd.
Shandong Weigao Pharmaceutical
Chongqing Yaoyou Pharmaceutical
Harbin Pharmaceutical Group Sanjing Pharmaceutical
Yangzhou Pharmaceutical
Rapid Life Drugs & Healthcare
Mits Healthcare Private Limited
Psychocare
Shinepro Lifesciences Pvt. Ltd.
REPLEK FARM DOOEL
Dr Reddy's Laboratories Ltd
Heilongjiang Fuhe Pharmaceutical
Segment by Type
15ml
60mL
Other
Segment by Application
Hospital
Clinic
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Piracetam Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Piracetam Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Piracetam Injection industry.
Chapter 3Historical (2018-2024) and forecast (2024-2034) volume and revenue analysis of Piracetam Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Piracetam Injection introduction, etc. Piracetam Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Piracetam Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.